chr1-161945711-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_007348.4(ATF6):​c.1805-12735G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.369 in 152,012 control chromosomes in the GnomAD database, including 10,630 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 10630 hom., cov: 32)

Consequence

ATF6
NM_007348.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.12

Publications

14 publications found
Variant links:
Genes affected
ATF6 (HGNC:791): (activating transcription factor 6) This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]
ATF6 Gene-Disease associations (from GenCC):
  • achromatopsia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • ATF6-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • achromatopsia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.396 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATF6NM_007348.4 linkc.1805-12735G>A intron_variant Intron 15 of 15 ENST00000367942.4 NP_031374.2 P18850A8K383
ATF6NM_001437597.1 linkc.1862-12735G>A intron_variant Intron 15 of 15 NP_001424526.1
ATF6NM_001410890.1 linkc.1802-12735G>A intron_variant Intron 15 of 15 NP_001397819.1
ATF6XM_011509309.1 linkc.1859-12735G>A intron_variant Intron 15 of 15 XP_011507611.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATF6ENST00000367942.4 linkc.1805-12735G>A intron_variant Intron 15 of 15 1 NM_007348.4 ENSP00000356919.3 P18850

Frequencies

GnomAD3 genomes
AF:
0.369
AC:
56090
AN:
151894
Hom.:
10613
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.334
Gnomad AMI
AF:
0.282
Gnomad AMR
AF:
0.283
Gnomad ASJ
AF:
0.462
Gnomad EAS
AF:
0.243
Gnomad SAS
AF:
0.370
Gnomad FIN
AF:
0.470
Gnomad MID
AF:
0.399
Gnomad NFE
AF:
0.400
Gnomad OTH
AF:
0.365
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.369
AC:
56136
AN:
152012
Hom.:
10630
Cov.:
32
AF XY:
0.368
AC XY:
27348
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.335
AC:
13878
AN:
41482
American (AMR)
AF:
0.283
AC:
4317
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.462
AC:
1600
AN:
3464
East Asian (EAS)
AF:
0.242
AC:
1256
AN:
5186
South Asian (SAS)
AF:
0.372
AC:
1790
AN:
4810
European-Finnish (FIN)
AF:
0.470
AC:
4954
AN:
10538
Middle Eastern (MID)
AF:
0.395
AC:
116
AN:
294
European-Non Finnish (NFE)
AF:
0.400
AC:
27197
AN:
67944
Other (OTH)
AF:
0.365
AC:
772
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1800
3599
5399
7198
8998
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
548
1096
1644
2192
2740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.383
Hom.:
32612
Bravo
AF:
0.352
Asia WGS
AF:
0.291
AC:
1014
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.26
DANN
Benign
0.41
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10918270; hg19: chr1-161915501; API